Find Dicycloplatin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 0kc57i4unb, Azane, 1-carboxycyclobutane-1-carboxylate, platinum(2+), 287402-09-9, Platinum(2+) 1-carboxycyclobutanecarboxylate ammoniate (1:2:2), Unii-0kc57i4unb, Dicycloplatin [who-dd]
Molecular Formula
C12H20N2O8Pt
Molecular Weight
515.38  g/mol
InChI Key
IIJQICKYWPGJDT-UHFFFAOYSA-L
FDA UNII
0KC57I4UNB

Dicycloplatin
Dicycloplatin is a third-generation, supramolecular platinum-based compound composed of carboplatin linked, by a strong hydrogen bond, to 1,1-cyclobutane dicarboxylate (CBDCA), with potential antineoplastic activity. Although the exact mechanism of action has yet to be fully elucidated, dicycloplatin appears to have a mechanism of action similar to that of other platinum-based compounds, which involves both DNA binding and the formation of DNA crosslinks. This mechanism results in the induction of apoptosis and cell growth inhibition. Compared to carboplatin alone, dicycloplatin shows enhanced solubility and stability in aqueous solution and appears to have a more favorable toxicity profile.
1 2D Structure

Dicycloplatin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
azane;cyclobutane-1,1-dicarboxylate;cyclobutane-1,1-dicarboxylic acid;platinum(2+)
2.1.2 InChI
InChI=1S/2C6H8O4.2H3N.Pt/c2*7-4(8)6(5(9)10)2-1-3-6;;;/h2*1-3H2,(H,7,8)(H,9,10);2*1H3;/q;;;;+2/p-2
2.1.3 InChI Key
IIJQICKYWPGJDT-UHFFFAOYSA-L
2.1.4 Canonical SMILES
C1CC(C1)(C(=O)O)C(=O)O.C1CC(C1)(C(=O)[O-])C(=O)[O-].N.N.[Pt+2]
2.2 Other Identifiers
2.2.1 UNII
0KC57I4UNB
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Cis-diammine(1,1-cyclobutanedicarboxylate)platinum(ii)

2. Diammine(1,1-cyclobutanedicarboxylate)platinum(ii)

2.3.2 Depositor-Supplied Synonyms

1. 0kc57i4unb

2. Azane, 1-carboxycyclobutane-1-carboxylate, Platinum(2+)

3. 287402-09-9

4. Platinum(2+) 1-carboxycyclobutanecarboxylate Ammoniate (1:2:2)

5. Unii-0kc57i4unb

6. Dicycloplatin [who-dd]

7. 1,1-cyclobutanedicarboxylic Acid, Compd. With (sp-4-2)-diammine(1,1-cyclobutanedi(carboxylato-kappao)(2-))platinum (1:1)

8. Platinum, Diammine(1,1-cyclobutanedi(carboxylato-kappao)(2-))-, (sp-4-2)-, 1,1-cyclobutanedicarboxylate (1:1)

9. Platinum, Diammine(1,1-cyclobutanedicarboxylato(2-)-kappao,kappao'')-, (sp-4-2)-, 1,1-cyclobutanedicarboxylate (1:1)

10. Db-119035

11. Cis-diammine(1,1-cyclobutanedicarboxylate)platinum(ii)

12. Q19776556

13. Azane;cyclobutane-1,1-dicarboxylate;cyclobutane-1,1-dicarboxylic Acid;platinum(2+)

14. 1,1-cyclobutanedicarboxylic Acid, Compd. With (sp-4-2)-diammine(1,1-cyclobutanedi(carboxylato-.kappa.o)(2-))platinum (1:1)

15. Platinum, Diammine(1,1-cyclobutanedi(carboxylato-.kappa.o)(2-))-, (sp-4-2)-, 1,1-cyclobutanedicarboxylate (1:1)

16. Platinum, Diammine(1,1-cyclobutanedicarboxylato(2-)-.kappa.o,.kappa.o'')-, (sp-4-2)-, 1,1-cyclobutanedicarboxylate (1:1)

2.4 Create Date
2009-12-07
3 Chemical and Physical Properties
Molecular Weight 515.38 g/mol
Molecular Formula C12H20N2O8Pt
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count10
Rotatable Bond Count2
Exact Mass515.086760 g/mol
Monoisotopic Mass515.086760 g/mol
Topological Polar Surface Area157 Ų
Heavy Atom Count23
Formal Charge0
Complexity317
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count5

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty